1
Clinical Trials associated with BMS-986447A Phase 1 Randomized, Double-blind, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single, Ascending Doses of BMS-986447 in Healthy Adult Participants
The purpose of the study is to evaluate the safety, tolerability and drug levels of single, oral doses of BMS-986447 in healthy participants.
100 Clinical Results associated with BMS-986447
100 Translational Medicine associated with BMS-986447
100 Patents (Medical) associated with BMS-986447
100 Deals associated with BMS-986447